Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors
PITTSBURGH, Nov. 16, 2023 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq:CTCX), a human biomaterials company (“Carmell”), today announced the addition of two independent directors to their Board.
Related news for (CTCX)
- CARMELL CORP REBRANDS AS LONGEVITY HEALTH HOLDINGS TO HIGHLIGHT BUSINESS FOCUS & GROWTH STRATEGY
- Carmell Announces Closing of Elevai Skincare Acquisition
- Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out
- 24/7 Market News Snapshot 02 January, 2025 – Carmell Corporation Common Stock (NASDAQ:CTCX)
- Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products